Effect of preparation conditions on morphology, drug content and release profiles of poly(hydroxybutyrate) microparticles containing piroxicam

被引:25
作者
Bazzo, G. C. [1 ]
Lemos-Senna, E. [2 ]
Goncalves, M. C. [3 ]
Pires, A. T. N. [1 ]
机构
[1] Univ Fed Santa Catarina, Dept Quim, POLIMAT, Grp Estudos Mat Polimer, BR-88040900 Florianopolis, SC, Brazil
[2] Univ Fed Santa Catarina, Dept Ciencias Farmaceut, Lab Farmacotecn, BR-88040900 Florianopolis, SC, Brazil
[3] Univ Estadual Campinas, Inst Quim, BR-13084862 Campinas, SP, Brazil
关键词
poly(hydroxybutyrate); microparticles; piroxicam; controlled release;
D O I
10.1590/S0103-50532008000500016
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
In this study, poly(hydroxybutyrate) microparticles containing piroxicam were prepared by the oil-in-water emulsion-solvent evaporation method. The effects of some process conditions on drug content were determined using a 21 factorial design. The piroxicam loading efficiency varied from 5.5 to 89.8 %. Hollow and irregular microparticles with drug crystals on their surfaces were obtained when 5 mL of chloroform was used as the internal phase. In the release study, all of the piroxicam was released to the dissolution medium (phosphate buffer pH 7.4) after 8 h. Small spherical microspheres with a rough and porous polymeric matrix were obtained when 20 mL of dichloromethane was used as the internal phase and isopropanol was added to the external aqueous phase. These microspheres controlled the piroxicam release for approximately 50 h. The results demonstrated that it is possible to obtain microparticles with specific characteristics by the optimization of the process conditions.
引用
收藏
页码:914 / 921
页数:8
相关论文
共 21 条
[1]
Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres [J].
Berkland, C ;
Kipper, MJ ;
Narasimhan, B ;
Kim, KK ;
Pack, DW .
JOURNAL OF CONTROLLED RELEASE, 2004, 94 (01) :129-141
[2]
FT-Raman and FT-IR studies of 1:2.5 piroxicam:: β-cyclodextrin inclusion compound [J].
Bertoluzza, A ;
Rossi, M ;
Taddei, P ;
Redenti, E ;
Zanol, M ;
Ventura, P .
JOURNAL OF MOLECULAR STRUCTURE, 1999, 481 :535-539
[3]
The application of polyhydroxyalkanoates as tissue engineering materials [J].
Chen, GQ ;
Wu, Q .
BIOMATERIALS, 2005, 26 (33) :6565-6578
[4]
Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration -: Effect of Labrafil addition on release in vitro [J].
Fernández-Carballido, A ;
Herrero-Vanrell, R ;
Molina-Martínez, IT ;
Pastoriza, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 279 (1-2) :33-41
[5]
Polymer microspheres for controlled drug release [J].
Freiberg, S ;
Zhu, X .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 282 (1-2) :1-18
[6]
In vitro and in vivo degradation studies for development of a biodegradable patch based on poly(3-hydroxybutyrate) [J].
Freier, T ;
Kunze, C ;
Nischan, C ;
Kramer, S ;
Sternberg, K ;
Sass, M ;
Hopt, UT ;
Schmitz, KP .
BIOMATERIALS, 2002, 23 (13) :2649-2657
[7]
Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology [J].
Freitas, S ;
Merkle, HP ;
Gander, B .
JOURNAL OF CONTROLLED RELEASE, 2005, 102 (02) :313-332
[8]
A floating-type oral dosage form for piroxicam based on hollow polycarbonate microspheres: In vitro and in vivo evaluation in rabbits [J].
Joseph, NJ ;
Lakshmi, S ;
Jayakrishnan, A .
JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) :71-79
[9]
Tailoring of the external and internal morphology of poly-3-hydroxy butyrate microparticles [J].
Martin, MA ;
Miguens, FC ;
Rieumont, J ;
Sanchez, R .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2000, 17 (02) :111-116
[10]
The influence of stirring rate on biopharmaceutical properties of Eudragit RS microspheres [J].
Mateovic, T ;
Kriznar, B ;
Bogataj, M ;
Mrhar, A .
JOURNAL OF MICROENCAPSULATION, 2002, 19 (01) :29-36